Literature DB >> 30679208

Acute and Evolving MRI of High-Altitude Cerebral Edema: Microbleeds, Edema, and Pathophysiology.

P H Hackett1, P R Yarnell2, D A Weiland3, K B Reynard3.   

Abstract

MR imaging of high-altitude cerebral edema shows reversible WM edema, especially in the corpus callosum and subcortical WM. Recent studies have revealed hemosiderin deposition in WM long after high-altitude cerebral edema has resolved, providing a high-altitude cerebral edema "footprint." We wished to determine whether these microbleeds are present acutely and also describe the evolution of all MR imaging findings. In 8 patients with severe high-altitude cerebral edema, we obtained 26 studies: 18 with 3T and 8 with 1.5T scanners, during the acute stage, recovery, and follow-up in 7 patients and acutely in 1 patient. Imaging confirmed reversible cytotoxic and vasogenic WM edema that unexpectedly worsened the first week during clinical improvement before resolving. The 3T SWI, but not 1.5T imaging, showed extensive microbleeds extending beyond areas of edema seen acutely, which persisted and with time coalesced. These findings support cytotoxic and vasogenic edema leading to capillary failure/leakage in the pathophysiology of high-altitude cerebral edema and provide imaging correlation to the clinical course.
© 2019 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2019        PMID: 30679208     DOI: 10.3174/ajnr.A5897

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  10 in total

Review 1.  High-altitude illness: Management approach.

Authors:  Gökhan Aksel; Şeref Kerem Çorbacıoğlu; Can Özen
Journal:  Turk J Emerg Med       Date:  2019-09-19

2.  Distinct pattern of microsusceptibility changes on brain magnetic resonance imaging (MRI) in critically ill patients on mechanical ventilation/oxygenation.

Authors:  Majda M Thurnher; Jasmina Boban; Martin Röggla; Thomas Staudinger
Journal:  Neuroradiology       Date:  2021-03-01       Impact factor: 2.804

3.  Atypical High-Altitude Cerebral Edema Presentation at an Altitude of Less Than 3000 Meters Elevation: A Case Report.

Authors:  Todd Bolotin; Kayla E Prokopakis; Bruce Becker
Journal:  Open Access Emerg Med       Date:  2022-03-29

4.  High Altitude Cerebral Edema: Improving Treatment Options.

Authors:  Rebecca Zelmanovich; Kevin Pierre; Patrick Felisma; Dwayne Cole; Matthew Goldman; Brandon Lucke-Wold
Journal:  Biologics (Basel)       Date:  2022-03-17

5.  Acute High-Altitude Cerebral Edema Presenting as Extensive Microbleeds along the Corpus Callosum without T2 Hyperintensity: A Case Report and Literature Review.

Authors:  Jin Young Son; Jee Young Kim; Sanghyuk Im
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-07-02

Review 6.  The impact of hypoxia on blood-brain, blood-CSF, and CSF-brain barriers.

Authors:  Jeff F Dunn; Albert M Isaacs
Journal:  J Appl Physiol (1985)       Date:  2021-07-15

7.  Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19.

Authors:  Shashank Agarwal; Rajan Jain; Siddhant Dogra; Penina Krieger; Ariane Lewis; Vinh Nguyen; Kara Melmed; Steven Galetta
Journal:  Stroke       Date:  2020-08-05       Impact factor: 7.914

8.  Abnormal brain activity in rats with sustained hypobaric hypoxia exposure: a resting-state functional magnetic resonance imaging study.

Authors:  Hui Yuan; Yong Wang; Peng-Fei Liu; Yun-Long Yue; Jin-Song Guo; Zhen-Chang Wang
Journal:  Chin Med J (Engl)       Date:  2019-11-05       Impact factor: 2.628

9.  Increase in Ventricle Size and the Evolution of White Matter Changes on Serial Imaging in Critically Ill Patients with COVID-19.

Authors:  Shashank Agarwal; Kara Melmed; Siddhant Dogra; Rajan Jain; Jenna Conway; Steven Galetta; Ariane Lewis
Journal:  Neurocrit Care       Date:  2021-03-05       Impact factor: 3.210

Review 10.  Recommendations for traveling to altitude with neurological disorders.

Authors:  Marika Falla; Guido Giardini; Corrado Angelini
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.